3M Co (MMM) stock
MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 20, 2026Score 15/3030% above fair value
$180.88−0.80 (-0.44%)
Close on Nov 17, 2026Market cap $93.47BP/E 27.0Yield 1.61%
3M operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
3M's operating income for the twelve months ending Sep 30, 2026 was $4.74B, down 3.7% year over year. For fiscal 2025 it was $4.63B, down 4.0% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $7.69B in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.63B | -4.0% |
| FY2024 | Dec 31, 2024 | $4.82B | – |
| FY2023 | Dec 31, 2023 | -$10.69B | -344.7% |
| FY2022 | Dec 31, 2022 | $4.37B | -40.7% |
| FY2021 | Dec 31, 2021 | $7.37B | +2.9% |
| FY2020 | Dec 31, 2020 | $7.16B | +16.0% |
| FY2019 | Dec 31, 2019 | $6.17B | -14.3% |
| FY2018 | Dec 31, 2018 | $7.21B | -6.3% |
| FY2017 | Dec 31, 2017 | $7.69B | +9.5% |
| FY2016 | Dec 31, 2016 | $7.03B | +1.2% |
| FY2015 | Dec 31, 2015 | $6.95B | -2.6% |
| FY2014 | Dec 31, 2014 | $7.14B | +7.0% |
| FY2013 | Dec 31, 2013 | $6.67B | +2.8% |
| FY2012 | Dec 31, 2012 | $6.48B | +4.9% |
| FY2011 | Dec 31, 2011 | $6.18B | +4.4% |
| FY2010 | Dec 31, 2010 | $5.92B | +22.9% |
| FY2009 | Dec 31, 2009 | $4.81B | -7.7% |
| FY2008 | Dec 31, 2008 | $5.22B | -15.7% |
| FY2007 | Dec 31, 2007 | $6.19B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.56B | +7.7% |
| Q2 FY2026 | Jun 30, 2026 | $984.00M | -13.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.40B | +12.1% |
| Q4 FY2025 | Dec 31, 2025 | $796.00M | -26.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.45B | +10.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.14B | -10.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.25B | +8.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.09B | +20.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.32B | – |
| Q2 FY2024 | Jun 30, 2024 | $1.27B | – |
| Q1 FY2024 | Mar 31, 2024 | $1.15B | -7.4% |
| Q4 FY2023 | Dec 31, 2023 | $899.00M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.10B | -174.5% |
| Q2 FY2023 | Jun 30, 2023 | -$9.36B | -8607.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.24B | -24.4% |
| Q4 FY2022 | Dec 31, 2022 | -$1.54B | -195.2% |
| Q3 FY2022 | Sep 30, 2022 | $4.16B | +132.4% |
| Q2 FY2022 | Jun 30, 2022 | $110.00M | -94.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.64B | -17.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.62B | -12.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.79B | -6.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.97B | +13.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.99B | +19.9% |
| Q4 FY2020 | Dec 31, 2020 | $1.85B | +39.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.91B | -5.1% |
| Q2 FY2020 | Jun 30, 2020 | $1.74B | +2.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.66B | +46.4% |
| Q4 FY2019 | Dec 31, 2019 | $1.33B | -25.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.01B | -0.2% |
| Q2 FY2019 | Jun 30, 2019 | $1.70B | -29.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.14B | +12.8% |
| Q4 FY2018 | Dec 31, 2018 | $1.78B | -0.3% |
| Q3 FY2018 | Sep 30, 2018 | $2.02B | +0.4% |
| Q2 FY2018 | Jun 30, 2018 | $2.40B | +11.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.01B | -42.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.79B | +21.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.01B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.15B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.74B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.47B | – |
See a number that looks wrong?